IOVA icon

Iovance Biotherapeutics
IOVA

Overview Fund Activity

299 hedge funds and large institutions have $1.79B invested in Iovance Biotherapeutics in 2024 Q4 according to their latest regulatory filings, with 58 funds opening new positions, 100 increasing their positions, 84 reducing their positions, and 36 closing their positions.

Holders
299
Holders Change
+16
Holders Change %
+5.65%
% of All Funds
3.98%
Holding in Top 10
7
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-22.22%
% of All Funds
0.09%
New
58
Increased
100
Reduced
84
Closed
36
Calls
$28.9M
Puts
$36.4M
Net Calls
-$7.54M
Net Calls Change
-$27M

Top Buyers

1
Man Group
1
Man Group
United Kingdom
$17.9M
2
UBS Group
2
UBS Group
Switzerland
$20M
3
BlackRock
3
BlackRock
New York
$174M
4
Morgan Stanley
4
Morgan Stanley
New York
$29.3M
5
Assenagon Asset Management
5
Assenagon Asset Management
Luxembourg
$12.9M

Top Sellers

1
PA
1
Perceptive Advisors
New York
$164M
2
SCM
2
Soleus Capital Management
Connecticut
$48.5M
3
Bank of America
3
Bank of America
North Carolina
$5.49M
4
Balyasny Asset Management
4
Balyasny Asset Management
Illinois
$20.9M
5
CCM
5
Cutter Capital Management
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$204M 27,534,340 +220,373 +0.8%
MFM
2
MHR Fund Management
New York
$181M 24,417,103 +420,000 +2%
BlackRock
3
BlackRock
New York
$174M 23,476,035 +1,992,367 +9%
PA
4
Perceptive Advisors
New York
$164M 22,112,266 -4,505,443 -17%
State Street
5
State Street
Massachusetts
$90.6M 12,249,282 -952,696 -7%
HRCM
6
Hood River Capital Management
Florida
$66.5M 8,991,573 +846,936 +10%
SCM
7
Soleus Capital Management
Connecticut
$48.5M 6,560,000 -1,968,500 -23%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$43.5M 5,871,420 +222,425 +4%
T. Rowe Price Investment Management
9
T. Rowe Price Investment Management
Maryland
$43.2M 5,834,456 -26,823 -0.5%
LFCM
10
Long Focus Capital Management
Puerto Rico
$38M 5,132,000 +600,000 +13%
Macquarie Group
11
Macquarie Group
Australia
$35.2M 4,750,934 +1,560,898 +49%
Artisan Partners
12
Artisan Partners
Wisconsin
$33.6M 4,542,168 -261,657 -5%
Goldman Sachs
13
Goldman Sachs
New York
$30.4M 4,110,056 -279,976 -6%
Morgan Stanley
14
Morgan Stanley
New York
$29.3M 3,959,839 +1,811,265 +84%
Principal Financial Group
15
Principal Financial Group
Iowa
$27M 3,646,787 -386,397 -10%
ACA
16
Avoro Capital Advisors
New York
$25.9M 3,500,000 -740,000 -17%
PAI
17
Palo Alto Investors
California
$22.5M 3,041,685 – –
Balyasny Asset Management
18
Balyasny Asset Management
Illinois
$20.9M 2,819,799 -1,652,777 -37%
UBS Group
19
UBS Group
Switzerland
$20M 2,704,469 +2,082,340 +335%
MB
20
MPM BioImpact
Massachusetts
$19.8M 2,673,905 +267,191 +11%
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
$19.7M 2,662,695 +1,248,778 +88%
T. Rowe Price Associates
22
T. Rowe Price Associates
Maryland
$19.4M 2,628,101 -474,811 -15%
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$18M 2,430,221 +360,629 +17%
Man Group
24
Man Group
United Kingdom
$17.9M 2,414,996 +2,414,996 New
Northern Trust
25
Northern Trust
Illinois
$17.9M 2,414,807 +166,231 +7%
1
2 3 4 5